India

Healthtech market in India to grow US$35b by 2030

E-pharmacy will have a market share of US$412b in 2030 from US$1.1b in 2022.

Healthtech market in India to grow US$35b by 2030

E-pharmacy will have a market share of US$412b in 2030 from US$1.1b in 2022.

Indian healthcare value pools to extend to US$450b by 2030

IP delivery stands as the highest contributor to the healthcare pool.

India’s X-ray systems market to increase by 3% in CAGR from 2023 to 2033

GlobalData said it stemmed from the prevalence of chronic diseases.

India’s AINU to see growth due to AHH stake

GlobalData said the strategic move allows AINU to expand its presence.

AI-driven healthcare needs to be generation inclusive: GlobalData

A recent survey showed the younger generation is more familiar with AI.

India shifts to early-stage investments in biologics and genomics

Its exit market remained strong in the first half of 2023.

India’s TB strategy may drive the creation of user-friendly medical devices

The mycobacterium tuberculosis tests market’s annual CAGR to grow by 4%.

India to account for 18% of APAC's surgical sutures market

GlobalData finds risks in traditional suturing techniques for India.

Outlook uncertain for India’s generic drug makers: Fitch

The country is expected to retain its position as ‘pharmacy of the world’ despite challenges.

GlobalData sees new biopsy device boosting India’s bone cancer treatment market

The newly patented device simplifies tissue extraction in a bone marrow biopsy.

Two in three Indian healthcare leaders unsure of defence vs. cyber threats

But two in five feel that their tech infrastructure can ensure patient data privacy.

India’s AI centres to drive significant growth in medical devices market

GlobalData projects a 5% CAGR growth for the market by 2030.

Apollo Hospitals collaborate with UAE-based hospital in telemedicine

The cooperation also covers training and laboratory referral services.

India eyes database on drug formulations in the country

This will help address issues on the quality of drugs in the market, Fitch Solutions said.